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Abstract
Pyrethroid insecticides are extensively used for pest control around the house, flea prevention for pets, and plant sprays 
for the home and in agriculture. Deltamethrin (DTM) is a Type II pyrethroid insecticide used to control a variety of 
insects in agriculture and domestic environments. The present study investigated the possible anxiogenic effects of DTM 
(1, 3, and 10 mg/kg) in rats using behavioral and neurochemical methods. We assessed general locomotor activity and 
behavior in the elevated plus maze and open field test. Striatal and hippocampal neurotransmitter and metabolite levels 
were also measured. DTM (i) reduced locomotion and rearing frequency, (ii) slightly increased the duration of immobility, 
(iii) reduced the time engaged in social interaction, (iv) reduced the percentage of entries into and time spent on the 
open arms of the elevated plus maze, (v) reduced the number of center crossings in the elevated plus maze, (vi) Striatal 
and hippocampal neurotransmitter and metabolite levels were also measured. DTM (i) reduced locomotion and rearing 
frequency, (ii) slightly increased the duration of immobility, (iii) reduced the time engaged in social interaction, (iv) reduced 
the percentage of entries into and time spent on the open arms of the elevated plus maze, (v) reduced the number of center 
crossings in the elevated plus maze, (vi) increased striatal serotonin neurotransmitter and its metabolite, and (vii) did not 
alter motor coordination on the rotarod, grooming duration in the open field test, rectal temperature, or hippocampal 
neurotransmitter levels. These data suggest that DTM at the present doses and under these experimental conditions 
presented a similar profile to that of anxiogenic drugs, unrelated with the increased serotonin neurotransmission.
Keywords: Deltamethrin. Pyrethroid. Anxiety. Behavior. Central neurotransmitters.
Resumo
Inseticidas piretróides são amplamente utilizados para controle de pragas, como na prevenção de pulgas em animais de 
estimação e sprays de plantas para a casa e na agricultura. Deltametrina (DTM) é um inseticida piretróide tipo II usado 
para controlar uma variedade de insetos na agricultura e ambientes domésticos. O presente estudo investigou os possíveis 
efeitos ansiogênicos de DTM (1, 3 e 10 mg/kg) em ratos, utilizando métodos comportamentais e neuroquímicos. Foi 
avaliada a atividade locomotora geral e comportamento no labirinto em cruz elevado e teste de campo aberto. Os níveis de 
neurotransmissores e metabólitos no estriado e hipocampo também foram mensurados. DTM (i) reduziu a locomoção e a 
frequência de levantar, (ii)  aumentou da duração da imobilidade, (iii) reduziu o tempo de interacção social, (iv) reduziu a 
percentagem de entradas e tempo gasto nos braços abertos do elevado labirinto em cruz, (v) reduziu o número de cruzamentos 
no centro do labirinto em cruz elevado, (vi) aumentou neurotransmissor serotonina e de seu metabólito estriatal, e (vii) não 
alterou a coordenação motora no rotarod, duração do grooming no teste de campo aberto,  temperatura retal, ou níveis de 
neurotransmissores do hipocampo. Estes dados sugerem que DTM nas presentes doses e sob estas condições experimentais 
apresentaram um perfil semelhante ao de drogas ansiogénicas, não relacionados ao aumento da serotonina estriatal. 
Palavras-chave: Deltametrina. Piretróide. Ansiedade. Comportamento. Neurotransmissores centrais.
Introduction
Pyrethroid insecticides are widely used in agricul-
ture and in the home to control a variety of insects 
and are considered neurotoxic1. They can be divided 
into two classes. Type 1 has no cyano group at the car-
boxyl a position (a-carboxyl), whereas Type 2 pres-
ents this cyano group2,3,4.
Braz. J. Vet. Res. Anim. Sci., São Paulo, v. 50,  n. 1,  p. 33-42, 2013
34
Deltamethrin (DTM, [(S)-a-cyano-d-phenoxyben-
zyl-(1R,3R)-e-(2,2-dibromovinyl)-2,2-dimethylcyc-
lo-propane-1-carboxylate]) is a pyrethroid derivative 
claimed to be one of the most potent products of Type 
2 insecticides. DTM acts by delaying the closure of 
sodium channels, resulting in a tail current character-
ized by slow sodium influx during the end of neuro-
nal depolarization1,5,6.
Exposure to pyrethroid insecticides can induce 
neurobehavioral effects in rodents and other species, 
including humans7,8,9,10. Aspects of open field behav-
ior and catalepsy11,12, conditioned behavior12,13,14, mo-
tor activity15,16, anxiety11,17  and aggressive behavior11.
Type II pyrethroids produce a syndrome associated 
with acute hyperglycemia. These responses are likely 
linked to the sympathoadrenal medullary system2,17,18. 
Additionally, other studies showed that low doses of 
DTM, a type II pyrethroid, induced severe neuro-
endocrine and autonomic responses, reflecting high 
levels of stress presumably caused by the neurotoxic 
properties of the insecticide17. Type II pyrethroids 
may act on g-aminobutyric acid (GABA) receptors as 
benzodiazepine antagonists8,19,20. 
Considering that pyrethroids can interfere with neu-
rotransmitter systems involved in anxiogenic effects, 
the present study investigated the effects of DTM, a 
Type II pyrethroid, in rats using a behavioral model re-
lated to anxiety and assessed its possible neurochemical 
effects. The rectal temperature was measured because 
thermoregulatory response following acute exposure 
to many toxic chemicals involves a regulated hypother-
mic response, characterized by activation of autonomic 
thermo effectors to raise heat loss and a behavioral 
preference for cooler temperatures21. 
Materials and methods
Animals
Adult male Wistar rats (Department of Pathology, 
Faculty of Veterinary Medicine and Zootechny, Uni-
versity of São Paulo, Brazil), weighing approximately 
300-310 g and 100 days old, were used. The animals 
were housed in polypropylene cages (40 x 50 x 20 
cm) under controlled temperature (20 ± 2°C) and hu-
midity (70 ± 5%) and a 12 h/12 h light/dark schedule 
(lights on at 6:00 AM). Food (Nuvilab CR1, species-
specific ration) and water (filtered in porcelain) were 
provided ad libitum throughout the study. Each rat 
was used in only one experiment. The rats were main-
tained in accordance with the guidelines of the Com-
mittee on the Care and Use of Laboratory Animal Re-
sources, National Research Council, USA.
Insecticide
Deltamethrin (DTM; S-a-cyano-3-phenoxyben-
zyl-(R)-cis-3-(2,2-dibromovinyl)-2,2-cimethylcy-
clopropane carboxylate; 10 mg/kg) was purchased 
from Quimio-Ind. Química S/A, dissolved in glycerol 
formaldehyde solution (Sigma, St. Louis, MO, USA; 
a racemic mixture produced by the condensation of 
glycerol with formaldehyde), and orally administered 
by gavage in volumes not exceeding 1 ml/kg body 
weight.
Open field test
General activity was evaluated in the open field 
test. The device was an arena with 96 cm diameter 
surrounded by a 25 cm high enclosure painted white 
and divided into 19 painted black parts. The appara-
tus was placed in a sound-proof room, 48 cm above 
the floor, and illuminated with a 40 W light bulb sus-
pended over the center of the field [55 lux]. Each ani-
mal was individually placed in the center of the arena, 
and the following parameters were measured over a 
period of 5 min: locomotor frequency (i.e., number 
of squares crossed with the four paws), rearing fre-
quency (i.e., number of times a rat stood erect on its 
hind legs with its forelegs in the air), and grooming 
frequency (i.e., washing movements over the head, 
licking the paws, fur licking, and tail/genital clean-
ing). A chronometer was used to measure the dura-
tion of immobility (i.e., total time in seconds without 
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spontaneous movements). To minimize the possible 
influences of circadian changes on open field behav-
ior, control and experimental animals were alternat-
ed. The device was cleaned with a 5% alcohol/water 
solution before placing the animals in it to eliminate 
the possible bias caused by odors left by the previous 
rats. Control and experimental rats were intermixed, 
and the tests were conducted between 8:00 AM and 
12:00 PM. Additionally, the animals were previously 
maintained for at least 90 min in access rooms under 
the same conditions as the test room.
Forty male rats were divided into four groups (n = 
10 rats per group) that received the following treat-
ments: DTM (1, 3, 10 mg/kg) or glycerol formalde-
hyde (1 ml/kg). Four sessions were performed, i.e, the 
rats were observed in the open field 30-35, 60-65, 90-
95, and 120-125 min after the treatments.
Rotarod test
In this test, the rats were placed with all four paws 
on a 2.5 cm diameter bar, 25 cm above the floor, which 
turned at 12 rotations per minute (rpm). Thirty naïve 
rats were used for this test. The rats were habituated to 
the apparatus in five daily sessions of 2 min each (14 
rpm) prior to the test. The training session consisted 
of 4 days of trials of 60 s each. Initially, 30 rats were 
used for this experiment, but only 15 rats remained 
on the rotarod for 60 s for all four consecutive ses-
sions and were selected for use in the test. After selec-
tion, these rats received the respective treatments, i.e. 
glycerol formaldehyde (1 ml/kg), or DTM (1, 3, or 10 
mg/kg). The tests were performed 30, 60, 90, 120, and 
180 min after the treatments. The percentage of rats 
that remained on the rotarod during each 60 min test 
was recorded. The apparatus was washed with a 5% 
ethanol solution prior to each behavioral test. Control 
and experimental rats were intermixed, and the tests 
were conducted between 8:00 AM and 12:00 PM.
Elevated plus maze
The elevated plus maze was constructed of wood, 
with two open arms (50 x 10 cm) and two closed arms 
of the same size, surrounded by 40 cm high walls. The 
entire apparatus was elevated 50 cm above the floor. 
Forty naïve male rats were divided into four groups (n 
= 10 rats per group) and received the following treat-
ments: DTM (1, 3, and 10 mg/kg) and glycerol form-
aldehyde (1 ml/kg). One hundred twenty minutes after 
the treatments, each rat was placed in the central square 
(10 x 10 cm), and the number of entries into each type 
of arm (with all four paws defining an entry) and time 
spent on the open and closed arms were recorded dur-
ing 5 min. The percentage of entries was calculated for 
each arm. The apparatus was washed with a 5% etha-
nol solution prior to each behavioral test. Control and 
experimental rats were intermixed, and the tests were 
conducted between 8:00 AM and 12:00 PM.
Social interaction test
Eighty naïve male rats were divided into four groups 
(n = 20 rats per group to obtains 10 pairs of the same 
treatment) and singly housed for 5 days prior to test-
ing. The social interaction test was performed in the 
open field apparatus, similarly to File22,23. Two days 
before the test, each rat was individually subjected to 
10 min familiarization sessions in the test arena. On 
the next day, the rats were paired by weight (i.e., no 
more than 10 g difference), and social interaction was 
observed for 10 min. Two hours after the administra-
tion of DTM (1 mg/kg) or glycerol formaldehyde (1 
ml/kg), the paired rats were placed in the center of 
the test arena to evaluate social interaction. The to-
tal time (in seconds) spent by the test pairs in active 
social interaction (i.e., sniffing, following, grooming, 
kicking, boxing, biting, and crawling under or over 
the partner) was recorded for 7.5 min. The appara-
tus was washed with a 5% ethanol solution prior to 
each behavioral test. Control and experimental rat 
pairs were intermixed, and the tests were conducted 
between 8:00 AM and 12:00 PM.
Rectal temperature
Rectal temperature was measured with an Impul-
stron® thermometer connected to a metallic material 
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sensor lubricated with Vaseline. The first measure-
ment was taken prior to and 120 min after the respec-
tive treatments, at the deltamethrin peak of effects on 
open field behaviors. The thermometer was cleaned 
with a 5% ethanol solution prior to each temperature 
measurement. Control and experimental naïve rats 
were intermixed, and the measurements were taken 
between 8:00 AM and 12:00 PM to prevent interfer-
ence caused by circadian variations.
Determination of neurotransmitter and metabolite 
levels
Twenty-seven six naïve male rats were divided into 
four groups (n = 9 rats per group) that received DTM 
(3 or 10 mg/kg) or glycerol formaldehyde (1 ml/kg). 
Two hours after the treatments, the rats were sacri-
ficed by decapitation under ice-cold hypothermia. 
The brains were collected and dissected on dry ice 
and prepared as previously described  De Souza Spi-
nosa et al.24. The striatum and hippocampus were 
dissected and separated within 3 min on an ice-cold 
plate, weighed, and homogenized (Polytrons) in 0.1M 
perchloric acid. A volume of 20 µ/mL of tissue (wet 
weight) of this solution was used for the analyses. To 
precipitate the proteins completely, the homogenates 
were left overnight in a refrigerator (4ºC) and then 
centrifuged (Eppendorf®) for 60 min. The superna-
tants were analyzed by high-performance liquid chro-
matography (HPLC, Shimadsu, model 6A) with a C-1 
column (Shimpak-ODS), electrochemical detector 
(Shimadsu, model 6A), sample injector, and integra-
tor (Shimadsu, model 6A Chromatopac). The levels 
of the following monoamines and their metabolites 
were measured: dopamine, 3,4-dihydroxyphenyl-
acetic acid (DOPAC), norepinephrine, 3-methoxy-
4-hydroxyphenylglycol (MHPG), homovanillic acid 
(HVA), serotonin (5-hydroxytryptamine [5-HT]), 
and 5-hydroxyindolacetic acid (5-HIAA).
Statistical analysis
The results are expressed as mean ± SD. Bartlett’s 
test was used to analyze the parametric data. Two-way 
analysis of variance (ANOVA) was used to analyze the 
open field and rotarod data. A one-way ANOVA fol-
lowed by Bonferroni´s multiple comparison test was 
used to evaluate differences between groups in the el-
evated plus maze, rotarod test, social interaction test 
and neurochemical data. The t-test was used to ana-
lyze the differences in rectal temperature. In all cases, 
the results were considered significant at p < 0.05. The 
statistical analyses were performed using GraphPad 
Prism software, version 5 (GraphPad, San Diego, CA, 
USA).
Results
Figure 1 shows the general locomotor activity of the 
rats treated with different doses of DTM in the open 
field. With regard to locomotor frequency, significant 
effects were found for treatment (F3,144 = 7.26, p = 
0.0001) and session (F3,144 = 67.34, p < 0.0001), with no 
interaction between factors (F9,144 = 1.41, p = 0.189). 
The Bonferroni test showed that the 10 mg/kg dose 
decreased locomotor frequency in the 120 min ses-
sion compared with the glycerol formaldehyde group. 
A similar result was found in the 10 mg/kg DTM 
dose from the 60 to 120 min sessions. With regard to 
rearing frequency, significant effects were found for 
treatment (F3,144  = 7.64, p= 0.004) and session (F3,144 
= 20.65, p = 0.0004), with no interaction between 
factors (F9,144 = 0.68, p = 0.727). The Bonferroni test 
showed that the 3 and 10 mg/kg doses decreased rear-
ing frequency in the 120 min session compared with 
the glycerol formaldehyde group. With regard to the 
duration of immobility, significant effects were found 
for DTM treatment (F3,144  = 3.04, p = 0.030) and ses-
sion (F3,144 = 27.35, p < 0.0001), with no interaction 
between factors 
(F9,144 = 1.06, p = 0.395). The Bonferroni test 
showed that 3 mg/kg DTM increased the duration of 
immobility in the 120 min session compared with the 
control and glycerol formaldehyde groups. No effects 
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were detected in rotarod performance between rats 
after DTM treatment (data not shown).
Figure 2 shows that DTM treatment reduced activity 
in the elevated plus maze compared with the control 
group. DTM reduced the percentage of entries into 
and time spent on the open arms (F3,39 = 3.430, p = 
0.027, and F3.39 = 6.893, p = 0.0009, respectively) and 
reduced the number of center crossings (F3,39 = 5.491, 
p = 0.003). The Bonferroni post hoc test showed that, 
relative to control group, 3.0 and 10 mg/kg DTM 120 
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Figure 1 - Open field behavior—(A) locomotion, (B) rearing, (C) immobility—in rats treated with 1, 3, or 10 mg/kg DTM 
and observed 30, 60, 90, and 120 min after treatment. The data are expressed as mean ± SD. n = 10/group. *p 
< 0.05, compared with glycerol formaldehyde group (two-way ANOVA followed by the Bonferroni multiple 
comparison test)
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min (p < 0.05) prior to the test reduced the time spent 
on the open arms. Also, it was observed a reduced 
percentage of open arms entries but only after 10 mg/
Kg treatment.  The number of center crossings in the 
3 and 10 mg/kg DTM groups were reduced compared 
with the glycerol formaldehyde group. 
The social interaction (Figure 2D) was different be-
tween groups with 1 mg/kg DTM decreased compared 
with the control group (Student t test, p < 0.0001).
DTM treatment did not alter rectal temperature in 
any of the groups (36.0 – 36.2°C).
The evaluation of the effects of DTM on striatal 
neurotransmitter and metabolite levels showed that 
5-HT (F2,26 = 13.93, p < 0.0001) levels of both DTM 
groups were increased in relation to control group 
and the 5-HIAA levels were increased in rats of the 
higher DTM dose (F2,26 = 4.43, p = 0.022) while no 
differences were detected in the 5-HIAA/DA ratio. 
No other striatal neurotransmitter or metabolite lev-
els were significantly modified by the treatment (Ta-
ble 1). The treatments also did not significantly alter 
hippocampal neurotransmitter levels (Table 2).
Discussion
The present results showed that DTM administration 
reduced locomotor and rearing frequency mainly in the 
120 min session. Therefore, activity in the elevated plus 
maze, social interaction, rectal temperature, and neu-
rotransmitter levels were evaluated 120 min after treat-
ment. Additionally, the 3 and 10 mg/kg doses of DTM 
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Figure 2 -  Time in open arms (A), entries in open arms(B)  and number of crossings (C0 in the elevated 
plus maze of rats treated with 1 mg/kg, 3 mg/kg, or  10 mg/kg DTM and observed 120 min 
after treatment. (D) Social interaction in rats treated with 1 mg/kg DTM. The data are 
expressed as mean ± SD. n = 10/group. *p < 0.05, ***p < 0.0001, compared with glycerol 
formaldehyde group (one-way ANOVA followed by the Tukey-Kramer multiple comparison 
test)
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altered these parameters. Both the elevated plus maze 
and social interaction test revealed an anxiogenic-like 
profile of the pesticide. Striatal 5-HT levels increased 
after treatment with 10 mg/kg DTM without affecting 
the 5-HIAA and 5-HIAA/5-HT ratio. No effects were 
observed in the rotarod test, on rectal temperature, or 
on hippocampal neurotransmitter levels. 
In the present study, glycerol formaldehyde was 
used to dissolve DTM. Laurent et al.25 demonstrated 
the absence of any toxic effects of glycerol formalde-
hyde, and the only effect observed after administra-
tion of a high dose (2000 mg/kg) was narcosis.
The open field test results suggest that locomotor 
activity decreased at 90 min (10 mg/kg) and 120 min 
(3 and 10 mg/kg), specifically with regard to loco-
motor frequency. Rearing frequency decreased only 
at 120 min (3 and 10 mg/kg). Diminished locomotor 
activity is consistent with numerous previous reports 
on the acute effects of pyrethroids. Several authors 
demonstrated reduced locomotor activity produced 
by exposure to different types of pyrethroids, includ-
ing DTM3,15,26,27,28,29. Interestingly, the decreased lo-
comotor and rearing frequencies were followed by 
an increased duration of immobility. Particularly, 
Table 1 – Effects of DTM administration on the striatum neurotransmitter’s levels and its metabolites. Data are 
presented as means±SD
Neurotransmitters/Metabolites
(ng/g of tissue) Glycerol Formaldehyde
DTM
(3mg/kg)
DTM
(10MG/kg)
DA 10946.0±2106.5 12139.7±2037.0 11802.4±1632.0
DOPAC 1063.2±149.5 976.3±317.6 1084.6±192.3
HVA 729.8±207.8 847.8±279.7 787.9±149.7
DOPAC/DA 0.099±0.016 0.083±0.027 0.092±0.013
HVA/DA 0.068±0.024 0.070±0.025 0.068±0.017
NA 26.4±8.1 32.8±14.4 28.8±9.0
MHPG 142.6±24.1 137.8±30.2 129.9±26.7
MHPG/NA 6.3±1.9 4.9±2.0 4.9±1.3
5-HT 812.3±81.4 1117.2±197.9* 1109.1±112.7***
5-HIAA 662.7±136.9 793.3±265.4 901.8±169.7*
5-HIAA/5-HT 0.812±0.124  0.700±0.153   0.824±0.194
DA- dopamine; DOPAC- 3,4-Dihydroxyphenylacetic acid; HVA-homovanillic acid; NA-noradrenaline; MHPG= 3-Methoxy-4-hydroxy-
phenylglycol ; 5-HT-serotonin; 5-HIAA- 5-Hydroxyindoleacetic acid.   * p< 0.02, ***  p < 0.0001 compared to respective glycerol formaldehyde 
group, N= 9 rats/group
Table 2 - Effects of DTM  administration on the hippocampal neurotransmitters levels. Data are 
presented as means±SD
Glycerol Formaldehyde DTM (3mg/Kg)
DTM
(10mg/kg)
DA 709.5±289.8 625.4±445.7 624.9±239.0
DOPAC 359.6±58.9 356.5±117.6 357.5±96.3
HVA 1580.6±286.5 1306.0±398.3 1187.6±378.7
DOPAC/DA 0.6±0.21 0.7±0.4 0.7±0.2
HVA/DA 2.5±0.8 2.8±1.8 2.4±1.2
NA 754.7±166.1 738.1±206.1 701.7±131.3
MHPG 391.2±53.8 346.7±62.2 349.0±60.8
MHPG/NA 0.5±0.1 0.5±0.1 0.5±0.1
5-HT N.D. N.D. N.D.
5-HIAA 6207.5±606.6 5617.7±613.4 5839.9±713.5
DA- dopamine; DOPAC- 3,4-Dihydroxyphenylacetic acid; HVA-homovanillic acid; NA-noradrenaline; MHPG= 3-Methoxy-4-
hydroxyphenylglycol ; 5-HT-serotonin; 5-HIAA- 5-Hydroxyindoleacetic acid.   N.D. = Not detected, N= 9 rats/group
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DTM produces dose-dependent decreases in loco-
motor activity10,27,30.
In the present study, oral DTM administration re-
duced locomotor activity but not motor coordina-
tion. Pham Huu et al.31 observed a decrease in motor 
coordination after 0.5-1.5 g/kg DTM, and Manna 
et al.32  found the same effect after 14.5–145 mg/kg 
DTM administration in rats. The lack of effects ob-
served here may be related to the lower dose used in 
the present study. 
Bhattacharya and Mitra33 showed that anxiogen-
ic drugs dose-dependently reduce locomotion and 
rearing behavior in rats in the open field. Therefore, 
the decreased open field activity after DTM admin-
istration may have been a consequence of increased 
“anxiety” and not motor behavior in general. In this 
respect, decreased locomotor and rearing frequencies 
were observed with an increased duration of immo-
bility. However, the lack of effects on motor coordina-
tion supports the hypothesis that DTM does not in-
terfere with motor function but interferes with emo-
tional parameters.
The elevated plus maze is a useful animal model for 
studying anxiolytic drugs. When rats were  placed in 
an elevated plus maze for the first time, its  behavior 
is largely based on its “anxiety” level. Rats treated with 
anxiolytic drugs, such as diazepam, tend to exhibit 
less anxiety-like behavior, spending more time in the 
open arms33,34. DTM reduced the percentage of time 
spent on the open arms, suggesting an anxiogenic-like 
effect. The number of entries into the open arms also 
decreased. These effects of DTM are similar to those 
observed with anxiogenic drugs17,34,35,36. The lowest 
levels of  center crossings may be a consequence of 
a decreased general spontaneous activity, but in ro-
dents increased levels of anxiety leads to hypoactivity 
in the open field37.
In the social interaction test, 1 mg/kg DTM reduced 
the time spent engaged in social interaction. These 
results confirm our hypothesis that DTM induces 
anxiety-like behavior. This conclusion is based on the 
results with anxiolytic and anxiogenic drugs used in 
the social interaction test, i.e., a reduction in the time 
engaged in social interaction indicates an anxiogenic 
effect of the drug, whereas an increase in this param-
eter indicates an anxiolytic effect23,38,39.
Thermoregulation in rats is an important factor 
for evaluating the toxic effects of pyrethroids. One 
of the effects of Type I pyrethroid exposure is hyper-
thermia, possibly attributable to extensive muscular 
activity40. In contrast, type II pyrethroids, such as 
DTM, can produce hypothermia41. The three doses 
used in the present study did not modify rectal tem-
perature, suggesting that the present doses do not 
induce severe toxicity.
DTM increased the striatal levels of 5-HT (3 and 10 
mg/kg) and of 5-HIAA. No differences were detect-
ed between the 5-HIAA/5-HT ratios of all groups. 
These data suggest that the synthesis and metabo-
lism of serotonin were increased but not its activ-
ity. Central 5HT is involved in anxiety42,43. The role 
of serotoninergic system on anxiety brain areas are 
inconsistently44. Low levels of this neurotransmit-
ter in the synaptic clef is correlated with anxiogen-
esis44,45,46,47. Striatal lesions in serotonin innervation 
leads to  moderate anxiogenic effects in the elevated 
plus maze44. On the contrary, in several elevated 
mazes as animal models of anxiety, serotoninergic 
agonists present anxiolytic  activity48. So, we sug-
gest that the increased anxiety levels here observed 
in both, elevated plus maze and social interaction 
behavioral models, were not correlated with the in-
creased activity in serotoninergic system. 
No alterations in dopamine or its metabolites, 
DOPAC and HVA, were observed either in the 
striatum or hippocampus. Moreover, no altera-
tions in norepinephrine or its metabolites were 
found. These data confirm our hypothesis that mo-
tor function did not critically impact the effects of 
DTM treatment.
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